JPRN-jRCT2080220384未知3 期
A phase II/III clinical study of R442 (Pegylated Interferon alfa-2a) for patients with chronic hepatitis B.
适应症
试验速览
- 阶段
- 3 期
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Male and Female patients aged 20 years-old or more, diagnosed chronic hepatitis B.
排除标准
- 未提供
研究者
相似试验
已完成
2 期
A phase II/III clinical study of R442(Pegylated Interferon alfa-2a) for patients with chronic hepatitis B.chronic hepatitis BJPRN-UMIN000000692CHUGAI PHARMACEUTICAL CO.LTD.260
未知
2 期
Phase II/III Clinical Study of R484iv (Ibandronic acid) for Primary OsteoporosisOsteoporosisJPRN-jRCT2080220364Chugai Pharmaceutical Co., Ltd. Taisho Pharmaceutical Co., Ltd.
未知
2 期
Phase II-III Clinical Study of CSG452(RG7201) in Patients with Type 2 DiabetesType 2 diabetesJPRN-jRCT2080221312Chugai Pharmaceutical Co., Ltd.220
未知
1 期
Phase I of RG3502 in Combination With RG1273HER2 positive Breast CancerJPRN-jRCT2080221197Chugai Pharmaceutical Co., Ltd.6
未知
2 期
The Phase II Study of Bardoxolone Methyl in Patients with Chronic Kidney Disease and Type 2 Diabetes; TSUBAKI StudyCKD patients with type 2 diabetesJPRN-jRCT2080222666Kyowa Hakko Kirin Co., Ltd.